GSE149632 dopamine 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE149632_dopamine_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE149632_dopamine_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE149632_dopamine_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE149632_dopamine_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

ribosomal protein S4 Y-linked 1

Gene

eukaryotic translation initiation factor 1A Y-linked

Gene

lysine demethylase 5D

Gene

paternally expressed 10

Gene

activated leukocyte cell adhesion molecule

Gene

heat shock protein family A (Hsp70) member 1A

Gene

solute carrier family 38 member 1

Gene

alpha-2-glycoprotein 1, zinc-binding

Gene

dehydrogenase/reductase 2

Gene

fatty acid binding protein 5

  • Gene

    ribosomal protein S4 Y-linked 1


  • Gene

    eukaryotic translation initiation factor 1A Y-linked


  • Gene

    lysine demethylase 5D


  • Gene

    paternally expressed 10


  • Gene

    activated leukocyte cell adhesion molecule


  • Gene

    heat shock protein family A (Hsp70) member 1A


  • Gene

    solute carrier family 38 member 1


  • Gene

    alpha-2-glycoprotein 1, zinc-binding


  • Gene

    dehydrogenase/reductase 2


  • Gene

    fatty acid binding protein 5

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.